Enact to Host Fourth Quarter 2023 Earnings Call February 7th
RALEIGH, N.C., Jan. 04, 2024 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq:ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 6, 2024. Enact will host a conference call to review fourth quarter 2023 financial results on February 7, 2024 at 8:00 a.m. (ET).
Related news for (ACT)
- Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
- Actuate Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
- Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
- Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
- Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer